NCT02026843View on ClinicalTrials.gov

Analysis of Biomarkers From Patients With Chorioretinal Diseases

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

February 29, 2028

Study Completion Date

April 30, 2031

Conditions

Diabetic RetinopathyMacular Degeneration

Interventions

DRUG

Chorioretinal diseases

chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration

Trial Locations (1)

700-721

RECRUITING

Dong Ho Park, Daegu

All Listed Sponsors

lead

Kyungpook National University Hospital

OTHER

NCT02026843 - Analysis of Biomarkers From Patients With Chorioretinal Diseases | Biotech Hunter | Biotech Hunter